Introduction to Biologic and Biosimilar Product Development and Analysis
Nagel, Karen M.
Introduction to Biologic and Biosimilar Product Development and Analysis by Karen M. Nagel. - 1 recurso en línea (XI, 109 páginas 4 ilustraciones a color) - AAPS Introductions in the Pharmaceutical Sciences 2522-834X Biomedical and Life Sciences (Springer-11642) .
Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars.
The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.
9783319984285
10.1007/978-3-319-98428-5 doi
Industria farmacéutica
RM301.25 2018 EB
Introduction to Biologic and Biosimilar Product Development and Analysis by Karen M. Nagel. - 1 recurso en línea (XI, 109 páginas 4 ilustraciones a color) - AAPS Introductions in the Pharmaceutical Sciences 2522-834X Biomedical and Life Sciences (Springer-11642) .
Recombinant DNA Technology -- Therapeutic Proteins -- Therapeutic Antibodies -- Analysis and Regulation of Biologics including Biosimilars.
The purpose of this book is to give a concise introduction to development and analysis of pharmaceutical biologics for those in the pharmaceutical industry who are switching focus from small molecules to biologics processing, analysis, and delivery. In order to maintain a limited focus, Introduction to Biologic and Biosimilar Product Development and Analysis, will deal only with peptides, proteins and monoclonal antibodies.
9783319984285
10.1007/978-3-319-98428-5 doi
Industria farmacéutica
RM301.25 2018 EB